Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (143)

« Back to Publications

Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia.

Bussmann BM. et al, (2026), BMJ Open, 16

Redefining respiratory sinus arrhythmia as respiratory heart rate variability: an international Expert Recommendation for terminological clarity.

Menuet C. et al, (2025), Nat Rev Cardiol, 22, 978 - 984

Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation.

Jani NR. et al, (2025), Cardiovasc Res, 121, 2189 - 2203

Safety and Feasibility of Magnetic Resonance Imaging Within the First Week Following Transvenous Pacing System Implantation.

Raby J. et al, (2025), Circulation, 152, 1393 - 1395

Increased uptake of specific metabolic substrates during cardiac resynchronization therapy despite no change in arterial concentrations: the very definition of metabolic flexibility.

Herring N. and Rider OJ., (2025), Eur Heart J

Multimodal, device-based therapeutic targeting of the cardiovascular autonomic nervous system.

Paton JFR. et al, (2025), Nat Rev Cardiol

Metabolic flexibility and reverse remodelling of the failing human heart.

Green PG. et al, (2025), Eur Heart J, 46, 2422 - 2433

Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β-adrenergic receptors.

van Weperen VYH. et al, (2025), J Physiol, 603, 1911 - 1921

Neurocardiology: translational advancements and potential.

Herring N. et al, (2025), J Physiol, 603, 1729 - 1779

Clinical neurocardiology: defining the value of neuroscience-based cardiovascular therapeutics - 2024 update.

Ajijola OA. et al, (2025), J Physiol, 603, 1781 - 1839

Molecular and cellular neurocardiology in heart disease.

Habecker BA. et al, (2025), J Physiol, 603, 1689 - 1728

Bayliss Starling Prize Lecture 2023: Neuropeptide-Y being 'unsympathetic' to the broken hearted.

Bussmann B. et al, (2025), J Physiol, 603, 1841 - 1864

Circulating neuropeptide Y dynamics and performance during exercise in heart failure patients with contemporary medical and device therapy.

Ayagama T. et al, (2025), Exp Physiol, 110, 401 - 409

Cardiac conduction system regeneration prevents arrhythmias after myocardial infarction.

Sayers JR. et al, (2025), Nat Cardiovasc Res, 4, 163 - 179

Safety and feasibility of magnetic resonance imaging within the first week following transvenous pacing system implantation

Raby J. et al, (2025), CIRCULATION, 152

Load More

1
2
3
4
5
6
7
...
»